Immunoaffinity profiling of tyrosine phosphorylation in cancer cells

Nature Biotechnology

Volumn 23, Issue 1, 2005, Pages 94-101

  Rush, John ^a   Moritz, Albrecht ^a   Lee, Kimberly A ^a   Guo, Ailan ^a   Goss, Valerie L ^a   Spek, Erik J ^a   Zhang, Hui ^b   Zha, Xiang Ming ^c   Polakiewicz, Roberto D ^a   Comb, Michael J ^a  

^a CELL SIGNALING TECHNOLOGY   (United States)

^b INSTITUTE FOR SYSTEMS BIOLOGY   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGENS; ENZYMES; IMMUNOLOGY; MASS SPECTROMETRY; POLYPEPTIDES; TUMORS;

CANCER CELLS; TYROSINE KINASES;

CELLS;

ADAPTOR PROTEIN; PHOSPHOTYROSINE; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; PEPTIDE; TYROSINE;

ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEOMICS; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING; ANIMAL; CELL LINE; CELL STRAIN 3T3; CHEMISTRY; LEUKEMIA CELL LINE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; METHODOLOGY; MOUSE; NEOPLASM; PHOSPHORYLATION; TUMOR CELL LINE;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; CHROMATOGRAPHY, LIQUID; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; JURKAT CELLS; MASS SPECTROMETRY; MICE; NEOPLASMS; NIH 3T3 CELLS; PEPTIDES; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEOMICS; SIGNAL TRANSDUCTION; TYROSINE;

EID: 21144458164     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt1046     Document Type: Article

References (41)

1. Blume-Jensen, P. & Hunter, T. Oncogenic kinase signalling. Nature 411, 355-365 (2001).
2. Sawyers, C.L. Rational therapeutic intervention in cancer: kinases as drug targets. Curr. Opin. Genet. Dev. 12, 111-115 (2002).
3. Mann, M. et al. Analysis of protein phosphorylation using mass spectrometry: deciphering the phosphoproteome. Trends Biotechnol. 20, 261-268 (2002).
4. Ficarro, S. B. et al. Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nat. Biotechnol. 20, 301-305 (2002).
5. Ficarro, S. et al. Phosphoproteome analysis of capacitated human sperm. Evidence of tyrosine phosphorylation of a kinase-anchoring protein 3 and valosin-containing protein/p97 during capacitation. J. Biol. Chem. 278, 11579-11589 (2003).
6. Pandey, A. et al. Analysis of receptor signaling pathways by mass spectrometry: identification of vav-2 as a substrate of the epidermal and platelet-derived growth factor receptors. Proc. Natl. Acad. Sci. USA 97, 179-184 (2000).
7. Pandey, A. et al. Identification of a novel immunoreceptor tyrosine-based activation motif-containing molecule, STAM2, by mass spectrometry and its involvement in growth factor and cytokine receptor signaling pathways. J. Biol. Chem. 275, 38633-38639 (2000).
8. Pandey, A. et al. Cloning of a novel phosphotyrosine binding domain containing molecule, Odin, involved in signaling by receptor tyrosine kinases. Oncogens 21, 8029-8036 (2002).
9. Salomon, A.R. et al. Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry. Proc. Natl. Acad. Sci. USA 100, 443-448 (2003).
10. Brill, L.M. et al. Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry. Anal. Chem. 76, 2763-2772 (2004).
11. Marcus, K., Immler, D., Sternberger, J. & Meyer, H.E. Identification of platelet proteins separated by two-dimensional gel electrophoresis and analyzed by matrix assisted laser desorption/ionization-time of flight-mass spectrometry and detection of tyrosine-phosphorylated proteins. Electrophoresis 21, 2622-2636 (2000).
12. Quadroni, M. & James, P. Phosphopeptide analysis. EXS 88, 199-213 (2000).
13. Schneider, U., Schwenk, H.U. & Bornkamm, G. Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int. J. Cancer 19, 621-626 (1977).
14. Srivastava, A.K. & St-Louis, J. Smooth muscle contractility and protein tyrosine phosphorylation. Mol. Cell. Biochem. 176, 47-51 (1997).
15. Eng, J.K., McCormack, A.L. & Yates, J.R., III. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J. Am. Soc. Mass Spectrom. 5, 976-989 (1994).
16. Kane, L.P., Lin, J. & Weiss, A. Signal transduction by the TCR for antigen. Curr. Opin. Immunol. 12, 242-249 (2000).
17. Calalb, M.B., Polte, T.R. & Hanks, S.K. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol. Cell. Biol. 15, 954-963 (1995).
18. Belsches, A.P., Haskell, M.D. & Parsons, S.J. Role of c-Src tyrosine kinase in EGF-induced mitogenesis. Front. Biosci. 2, d501-d518 (1997).
19. Bache, K.G., Raiborg, C., Mehlum, A., Madshus, I.H. & Stenmark, H. Phosphorylation of Hrs downstream of the epidermal growth factor receptor. Eur. J. Biochem. 269, 3881-3887 (2002).
20. Schaller, M.D. et al. Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Mol. Cell. Biol. 14, 1680-1688 (1994).
21. Bouton, A.H., Riggins, R.B. & Bruce-Staskal, P.J. Functions of the adapter protein Cas: signal convergence and the determination of cellular responses. Oncogene 20, 6448-6458 (2001).
22. Curtis, D.J. et al. Adaptor protein SKAP55R is associated with myeloid differentiation and growth arrest. Exp. Hematol. 28, 1250-1259 (2000).
23. Wang, Y.H., Li, F., Schwartz, J.H., Flint, P.J. & Borkan, S.C. c-Src and HSP72 interact in ATP-depleted renal epithelial cells. Am. J. Physiol. Cell Physiol. 281, C1667-C1675 (2001).
24. Frame, M.C., Fincham, V.J., Carragher, N.O. & Wyke, J.A. v-Src's hold over actin and cell adhesions. Nat. Rev. Mol. Cell Biol. 3, 233-245 (2002).
25. Pulford, K. et al. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM)-ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood 89, 1394-1404 (1997).
26. Morris, S.W. et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263, 1281-1284 (1994).
27. Fujimoto, J. et al. Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). Proc. Natl. Acad. Sci. USA 93, 4181-4186 (1996).
28. MacCoss, M.J. et al. Shotgun identification of protein modifications from protein complexes and lens tissue. Proc. Natl. Acad. Sci. USA 99, 7900-7905 (2002).
29. Bai, R.Y., Dieter, P., Peschel, C., Morris, S.W. & Duyster, J. Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-ã to mediate its mitogenicity. Mol. Cell. Biol. 18, 6951-6961 (1998).
30. van der Geer, P., Wiley, S., Gish, G.D. & Pawson, T. The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions. Curr. Biol. 6, 1435-1444 (1996).
31. Zamo, A. et al. Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death. Oncogene 21, 1038-1047 (2002).
32. Zhang, Q. et al. Multilevel dysregulation of STAT3 activation in anaplastic lymphoma kinase-positive T/null-cell lymphoma. J. Immunol. 168, 466-474 (2002).
33. Khoury, J.D. et al. Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK(+) and ALK(-) anaplastic large cell lymphoma. Clin. Cancer Res. 9, 3692-3699 (2003).
34. Darnell, J.E. Jr., Kerr, I.M. & Stark, G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421 (1994).
35. Szebeni, A., Hingorani, K., Negi, S. & Olson, M.O. Role of protein kinase CK2 phosphorylation in the molecular chaperone activity of nucleolar protein b23. J. Biol. Chem. 278, 9107-9115 (2003).
36. Bischof, D., Pulford, K., Mason, D.Y. & Morris, S.W. Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis. Mol. Cell. Biol. 17, 2312-2325 (1997).
37. Carr, S. et al. The need for guidelines in publication of peptide and protein identification data: working group on publication guidelines for peptide and protein identification data. Mol. Cell. Proteomics 3, 531-533 (2004).
38. Nesvizhskii, A.I., Keller, A., Kolker, E. & Aebersold, R. A statistical model for identifying proteins by tandem mass spectrometry. Anal. Chem. 75, 4646-4658 (2003).
39. Hornbeck, P.V., Chabra, I., Kornhauser, J.M., Skrzypek, E. & Zhang, B. PhosphoSite: A bioinformatics resource dedicated to physiological protein phosphorylation. Proteomics 4, 1551-1561 (2004).
40. Rappsilber, J., Ishihama, Y. & Mann, M. Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal. Chem. 75, 663-670 (2003).
41. Gerber, S.A., Rush, J., Stemman, O., Kirschner, M.W. & Gygi, S.P. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc. Natl. Acad. Sci. USA 100, 6940-6945 (2003).